Correlation between blood lipid level and gastric cancer

doi:10.3760/cma.j.cn371439-20221103-00036

Abstract

Abstract:

Patients with gastric cancer often have different degrees of dyslipidemia， and the level of lipid changes is closely related to the occurrence， development and prognosis of gastric cancer. The mechanism of lipid metabolism in gastric cancer has also attracted much attention， and it may be related to the reverse cholesterol transport function， antioxidant and anti-inflammatory properties of high-density lipoprotein cholesterol. In addition， statins may reduce the risk of gastric cancer and associated mortality. Further research on the correlation between blood lipid levels and gastric cancer is aimed to provide new ideas for the future prevention and precision diagnosis and treatment of gastric cancer.

Key words: Stomach neoplasms, Dyslipidemia, Hydroxymethylglutaryl-CoA reductase inhibitors

Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen. Correlation between blood lipid level and gastric cancer[J]. Journal of International Oncology, 2023, 50(3): 183-185.

References 27

[1]	He Y, Wang Y, Luan F, et al. Chinese and global burdens of gastric cancer from 1990 to 2019[J]. Cancer Med, 2021, 10(10): 3461-3473. DOI: 10.1002/cam4.3892. doi: 10.1002/cam4.3892
[2]	陈行辉, 李昌芳. 血脂水平与癌症的相关性研究进展[J]. 医学综述, 2018, 24(18): 3608-3612. DOI: 10.3969/j.issn.1006-2084.2018.18.014. doi: 10.3969/j.issn.1006-2084.2018.18.014
[3]	Nam SY, Park BJ, Nam JH, et al. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development[J]. Gastrointest Endosc, 2019, 90(3): 448-456. e1. DOI: 10.1016/j.gie.2019.04.232. doi: S0016-5107(19)31659-1 pmid: 31034810
[4]	Sun H, Huang X, Wang Z, et al. Triglyceride-to-high density lipoprotein cholesterol ratio predicts clinical outcomes in patients with gastric cancer[J]. J Cancer, 2019, 10(27): 6829-6836. DOI: 10.7150/jca.35939. doi: 10.7150/jca.35939 pmid: 31839817
[5]	Li F, Du H, Li S, et al. The association between metabolic syndrome and gastric cancer in Chinese[J]. Front Oncol, 2018, 8: 326. DOI: 10.3389/fonc.2018.00326. doi: 10.3389/fonc.2018.00326 pmid: 30191141
[6]	Pih GY, Gong EJ, Choi JY, et al. Associations of serum lipid level with gastric cancer risk, pathology, and prognosis[J]. Cancer Res Treat, 2021, 53(2): 445-456. DOI: 10.4143/crt.2020.599. doi: 10.4143/crt.2020.599 pmid: 33253515
[7]	阎巍, 刘俊田, 刘子豪, 等. 血脂代谢与胃癌发病风险相关性的病例对照研究[J]. 中国肿瘤临床, 2021, 48(4): 186-191. DOI: 10.3969/j.issn.1000-8179.2021.04.965. doi: 10.3969/j.issn.1000-8179.2021.04.965
[8]	Wu Y, Xin J, Loehrer EA, et al. High-density lipoprotein, low-density lipoprotein and triglyceride levels and upper gastrointestinal cancers risk: a trans-ancestry Mendelian randomization study[J]. Eur J Clin Nutr, 2022, 76(7): 995-1002. DOI: 10.1038/s41430-022-01078-6. doi: 10.1038/s41430-022-01078-6
[9]	姜媛媛, 张琰. 初发胃癌分化程度与患者空腹血脂水平的相关性[J]. 中国老年学杂志, 2017, 37(14): 3502-3503. DOI: 10.3969/j.issn.1005-9202.2017.14.055. doi: 10.3969/j.issn.1005-9202.2017.14.055
[10]	Shen JG, Jin LD, Dong MJ, et al. Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival[J]. Transl Cancer Res, 2020, 9(10): 6206-6213. DOI: 10.21037/tcr-20-1220. doi: 10.21037/tcr-20-1220 pmid: 35117231
[11]	Shin HJ, Roh CK, Son SY, et al. Prognostic value of hypocholesterolemia in patients with gastric cancer[J]. Asian J Surg, 2021, 44(1): 72-79. DOI: 10.1016/j.asjsur.2020.08.014. doi: 10.1016/j.asjsur.2020.08.014
[12]	Hu D, Peng F, Lin X, et al. Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study[J]. BMC Cancer, 2018, 18(1): 785. DOI: 10.1186/s12885-018-4596-y. doi: 10.1186/s12885-018-4596-y pmid: 30081869
[13]	Ma MZ, Yuan SQ, Chen YM, et al. Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer[J]. Onco Targets Ther, 2018, 11: 2169-2176. DOI: 10.2147/OTT.S156690. doi: 10.2147/OTT.S156690
[14]	Yi J, Ren L, Wu J, et al. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer[J]. Ann Transl Med, 2019, 7(16): 380. DOI: 10.21037/atm.2019.07.59. doi: 10.21037/atm.2019.07.59 pmid: 31555694
[15]	Bian X, Liu R, Meng Y, et al. Lipid metabolism and cancer[J]. J Exp Med, 2021, 218(1): e20201606. DOI: 10.1084/jem.20201606. doi: 10.1084/jem.20201606
[16]	Maan M, Peters JM, Dutta M, et al. Lipid metabolism and lipophagy in cancer[J]. Biochem Biophys Res Commun, 2018, 504(3): 582-589. DOI: 10.1016/j.bbrc.2018.02.097. doi: 10.1016/j.bbrc.2018.02.097
[17]	Ganjali S, Ricciuti B, Pirro M, et al. High-density lipoprotein components and functionality in cancer: state-of-the-art[J]. Trends Endocrinol Metab, 2019, 30(1): 12-24. DOI: 10.1016/j.tem.2018.10.004. doi: 10.1016/j.tem.2018.10.004
[18]	Soran H, Schofield JD, Durrington PN. Antioxidant properties of HDL[J]. Front Pharmacol, 2015, 6: 222. DOI: 10.3389/fphar.2015.00222. doi: 10.3389/fphar.2015.00222 pmid: 26528181
[19]	Kazi DS, Penko JM, Bibbins-Domingo K. Statins for primary prevention of cardiovascular disease: review of evidence and recommendations for clinical practice[J]. Med Clin North Am, 2017, 101(4): 689-699. DOI: 10.1016/j.mcna.2017.03.001. doi: 10.1016/j.mcna.2017.03.001
[20]	Chushi L, Wei W, Kangkang X, et al. HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells[J]. Gene, 2016, 587(1): 42-47. DOI: 10.1016/j.gene.2016.04.029. doi: 10.1016/j.gene.2016.04.029 pmid: 27085483
[21]	Seo SI, Park CH, Kim TJ, et al. Aspirin, metformin, and statin use on the risk of gastric cancer: a nationwide population-based cohort study in Korea with systematic review and meta-analysis[J]. Cancer Med, 2022, 11(4): 1217-1231. DOI: 10.1002/cam4.4514. doi: 10.1002/cam4.4514
[22]	Yuan M, Han S, Jia Y, et al. Statins are associated with improved survival of patients with gastric cancer: a systematic review and meta-analysis[J]. Int J Clin Pract, 2022, 2022: 4938539. DOI: 10.1155/2022/4938539. doi: 10.1155/2022/4938539
[23]	Kwon TJ, Kim TJ, Lee H, et al. Statin use decreases the risk of metachronous gastric cancer in patients without Helicobacter pylori infection[J]. Cancers (Basel), 2021, 13(5): 1020. DOI: 10.3390/cancers13051020. doi: 10.3390/cancers13051020
[24]	Cheung KS, Chan EW, Wong AYS, et al. Statins were associated with a reduced gastric cancer risk in patients with eradicated Helicobacter pylori infection: a territory-wide propensity score matched study[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(2): 493-499. DOI: 10.1158/1055-9965.EPI-19-1044. doi: 10.1158/1055-9965.EPI-19-1044
[25]	Kwon MJ, Kang HS, Kim JH, et al. Association between statin use and gastric cancer: a nested case-control study using a national health screening cohort in Korea[J]. Pharmaceuticals (Basel), 2021, 14(12): 1283. DOI: 10.3390/ph14121283. doi: 10.3390/ph14121283
[26]	Liu Q, Xia H, Zhou S, et al. Simvastatin inhibits the malignant behaviors of gastric cancer cells by simultaneously suppressing YAP and β-catenin signaling[J]. Onco Targets Ther, 2020, 13: 2057-2066. DOI: 10.2147/OTT.S237693. doi: 10.2147/OTT.S237693
[27]	Ortiz N, Delgado-Carazo JC, Díaz C. Importance of mevalonate pathway lipids on the growth and survival of primary and metastatic gastric carcinoma cells[J]. Clin Exp Gastroenterol, 2021, 14: 217-228. DOI: 10.2147/CEG.S310235. doi: 10.2147/CEG.S310235 pmid: 34103960